Enteral Feeding Formulas Market - Latest Advancement & Future Trends (2024-2032)

Enteral Feeding Formulas Market Synopsis:

Enteral Feeding Formulas Market Size Was Valued at USD 6.90 Billion in 2023 and is Projected to Reach USD 12.90 Billion by 2032, Growing at a CAGR of 7.2 % From 2024-2032.

The Enteral Feeding Formulas market refers to a broad spectrum of targeted nutritional foods meant for administration through tubes for individuals who cannot eat through the mouth due to diseases or illnesses such as dysphagia, gastrointestinal diseases, neurological diseases, or critical illness. These formulas are given through feeding tubes which give, proteins, carbohydrates, fats vitamins, and minerals in a form that can be easily digested and absorbed by the body. The market is split into various categories depending on the type of formulas which include the standard, semi-elemental, or elemental formulas that fit the nutritional needs of the patients.

Enteral feeding Formula is an emerging and fast-growing sector of the healthcare & Nutritional industry, which deals with Enteral nutritional products and formula, which is not possible through oral mouth intakes. This market covers many forms of formulas, the development of the eighteen standard, semi-elemental, elemental types or products according to the individual patient needs of the medical conditions, including neurological diseases, cancer, gastrointestinal and critical illness patients, and so on. Since more people are living longer and the incidence of conditions that require the intake of nutrients through tubes is on the rise, the enteral nutrition market is growing steadily. There is a growing appreciation by healthcare givers of enteral feeding has been established as an important aspect in patient treatment in especially hospitals and extended health facilities where patients may need to be fed continuously to meet some specific goals of recovery or enhanced quality of life.

Besides demographic and health dynamics that drive the Enteral Feeding Formulas Market, the market is highly competitive and those players who are in the forefront are aiming at differentiation and innovation. Manufacturers are focusing intensively on innovations in formulations which can address certain dietary needs of clients for which they are developing gluten-free, lactose free or low sugar formulas which has increased their market appeal among healthcare providers and clients. Another influential factor that directly regulates the market is the regulating units, such as the US Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) that maintain the necessary standards of safety, efficacy and labelling of enteral nutrition products in their respective regions. Also, home healthcare and telemedicine segments are also emerging as a new growth driver for the market because a large number of patients are being managed in home settings where enteral feeding is feasible and safe but requires appropriate supervision.

Enteral Feeding Formulas Market Trend Analysis:

Shift Toward Personalized Nutrition in Enteral Feeding Formulas

• A key new development for the Enteral Feeding Formulas Market is the increasing focus on individualized nutrition interventions for patients requiring enteral nutrition support. Because the role of nutrition in managing chronic diseases and various recovery processes is gradually gaining popularity among healthcare organizations, suppliers are focusing on creating new enteral formulas that may meet individual patient needs and medical restrictions. This trend is being propelled by technological improvements in nutritional science that enable producers to develop innovative products that meet several exact necessities, including renal failure, diabetes mellitus, metabolic complication, and food intolerances. Patient-centered nutrition is also evident from using parameters such as patient age, weight, gender, and disease state to custom-make for complication simulations. This approach does not only increase the effectiveness of enteral feeding but also helps to make patients more compliant to their meal diets because people are more willing to follow a diet which they set for their selves.

Expansion into Emerging Markets for Enteral Feeding Formulas

• One of the biggest growth opportunities in the context of the Enteral Feeding Formulas Market is Merging into emerging economies mainly because of raising awareness of healthcare and nutritional requirements. When more economically advanced such as Asia-Pacific, Latin America, and African countries, people realize the need to take foods that do not cause harm to their bodies more so where diseases are easily contracted due to aging. The enteral feeding formula scale has scaled up in these emerging markets and offers a good opportunity for product adaptation for local dietary preferences and health issues. In addition, there will be an increase in demand for nutritional support when there is a proper healthcare facility and medical health check-up thus requiring nutritional supplement for hospitalized and home health care patients. Businesses can leverage this situation by investing in affordable formulas that are a good fit for the region’s cultural characteristics and unique health issues related to poor nutrition and the consumption of fatty foods. New entrants to the market can enter partnerships with local providers of health care products, distributors, and government agencies, so that they can access the market easily and expand healthcare products’ availability to the consumers.

Enteral Feeding Formulas Market Segment Analysis:

The enteral Feeding Formulas Market is Segmented based on age category, application, end user, and region

By Age Category, Adult segment is expected to dominate the market during the forecast period

• The adult segment is expected to contribute to the largest market share for Enteral Feeding Formulas in the duration of the forecast period owing to the higher morbidity in chronic diseases and critical health situations requiring enteral nutrition support. Patients who develop critical illnesses including cancer, neurological diseases, and gastrointestinal diseases, will sometimes need enteral feeding to supplement their nourishment and aid their healing process. The increased aging population also supports this trend, due to the increased prevalence of diseases that affect food consumption through oral mechanisms. Also, the increased number of adults being hospitalized or placed in long-term care opens up the market for Enteral Nutrition for adults, most of whom have special macronutrient and micronutrient needs.

By Application, the Oncology segment expected to held the largest share

• Based on the segment, oncology is expected to dominate the enteral feeding formulas market over the forecast period due to elevated incidences of cancer and the need for proper nutrition in cancer treatment. Unfortunately, during cancer treatment, a variety of problems associated with eating might occur including nausea, vomiting, dysphagia, and anorexia. It thus becomes a critical solution to get enteral feeds and the needed nutrients and calories the body requires during this taxing phase. Oncology patients specifically require enteral nutrition to kept strong, and nourished, build immunity, and enhance their quality of life.

Enteral Feeding Formulas Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America is expected to persist to dominate the Enteral Feeding Formulas Market over the forecast period due to factors such as a growing geriatric population, rising incidence of diseases, and superior healthcare facilities. The region is most notably, the United States has a large market share with around 40% of the global market in the year 2023. This leadership position is underpinned by the increased need for enteral nutrition products in hospitals, extended care facilities, and for home administration to patients with a variety of medical needs.
• Also, formulation, composition, and delivery methods of enteral feeding formulas are being developed more and more making the solutions better and easier to administers. Businesses are now shifting more and more to creating new targeted products for certain diseases including cancer, neurological and gastrointestinal diseases. Many works in pushing the use of enteral nutrition products in the region also comes from government support in its implementation and policy making thereby further enhancing market growth.

Active Key Players in the Enteral Feeding Formulas Market:

• Abbott Laboratories (United States)
• B. Braun Melsungen AG (Germany)
• Danone S.A. (France)
• Fresenius Kabi AG (Germany)
• Gerber Products Company (Nestlé) (United States)
• Mead Johnson Nutrition Company (Reckitt Benckiser Group) (United States)
• Nestlé Health Science (Switzerland)
• Nutricia (Danone) (Netherlands)
• Purdue Pharma L.P. (United States)
• REHADU (Germany)
• ROCKTENN (United States)
• Siemens Healthineers (Germany)
• Sonneborn, LLC (United States)
• Thermo Fisher Scientific Inc. (United States)
• Zoetis Inc. (United States)
• Other Active Players

Key Industry Developments in the Enteral Feeding Formulas Market:

• In September 2023, to address the lack of supply in the institutional sector, Abbott announced plans to increase the production of a variety of adult enteral formulas for the retail market.
• In February 2023, to find new nutraceuticals for regulating food intake, Nestlé and EraCal Therapeutics started a research partnership.